Publications & Abstracts

The Endobarrier gastrointestinal liner system (by GI Dynamics®) is an endoscopically-delivered device that offers an alternative to gastric bypass...

The endoscopically delivered duodenal-jejunal bypass liner (DJBL) exhibits robust metabolic effects in obese subjects with type 2 diabetes...

Endoscopic implantation of a duodenal-jejunal bypass liner (DJBL) is a novel bariatric technique to induce weight loss and remission of type 2...

This study was performed to determine the safety, efficacy, and feasibility of delivering the DJBL with the patient under conscious sedation...

We recommend consideration of the DJBS as a therapy alternative for the treatment of adult patients (minimum age: 18 years) with type 2 diabetes...

To report Type 2 diabetes-related outcomes after the implantation of a duodenal-jejunal bypass liner device and to investigate the role of proximal...

Bariatric surgery reduces nonalcoholic fatty liver disease (NAFLD). We investigated the effects of duodenal-jejunal bypass liner (DJBL), nonsurgical...

We sought to identify clinical factors associated with weight loss in obese patients treated with the DJBL for 1 year.

To gain insight into the mediators involved, we investigated factors regulating glucose homeostasis in patients with type 2 diabetes treated with...

We conducted a nonsystematic review on worldwide articles published on the MEDLINE database to ascertain progress in the development and use of the...